Loading chat...

FL H4429

Bill

Official Source

Status

Introduced

11/21/2019

Primary Sponsor

Holly Raschein

Click for details

Origin

House of Representatives

2020 Regular Session

AI Summary

  • Appropriates $1,021,726 in nonrecurring funds from the General Revenue Fund for fiscal year 2020-2021
  • Funds the Extended-Release Injectable Naltrexone Program, a medication-assisted treatment for opioid and alcohol addiction
  • Designates the Department of Children and Families as the administering agency
  • Effective date of July 1, 2020

Legislative Description

Extended-Release Injectable Naltrexone Program

Last Action

See HB 5001 (line item 375)

3/19/2020

Committee Referrals

Appropriations1/14/2020
Health Care Appropriations Subcommittee11/25/2019

Full Bill Text

No bill text available